Next Article in Journal
Informational Stories: A Complementary Strategy for Patients and Caregivers with Brain Metastases
Previous Article in Journal
“This is a kind of Betrayal”: A Qualitative Study of Disability after Breast Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 16
Issue 3
10.3747/co.v16i3.447
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Adjuvant Interferon Alfa for Melanoma: New Evidence-Based Treatment Recommendations?

by
Axel Hauschild
Department of Dermatology, University of Kiel, Schittenhelmstr. 7, 24105 Kiel, Germany
Curr. Oncol. 2009, 16(3), 3-6; https://doi.org/10.3747/co.v16i3.447
Submission received: 4 February 2009 / Revised: 8 April 2009 / Accepted: 11 April 2009 / Published: 1 May 2009

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Malignant melanoma of the skin is the most frequent cause of mortality in skin cancer. Despite various efforts toward increased early detection and prevention of melanoma, approximately 20% of patients will die because of disseminated metastases. [...]
Keywords: melanoma; adjuvant therapy; interferon alfa melanoma; adjuvant therapy; interferon alfa

Share and Cite

MDPI and ACS Style

Hauschild, A. Adjuvant Interferon Alfa for Melanoma: New Evidence-Based Treatment Recommendations? Curr. Oncol. 2009, 16, 3-6. https://doi.org/10.3747/co.v16i3.447

AMA Style

Hauschild A. Adjuvant Interferon Alfa for Melanoma: New Evidence-Based Treatment Recommendations? Current Oncology. 2009; 16(3):3-6. https://doi.org/10.3747/co.v16i3.447

Chicago/Turabian Style

Hauschild, Axel. 2009. "Adjuvant Interferon Alfa for Melanoma: New Evidence-Based Treatment Recommendations?" Current Oncology 16, no. 3: 3-6. https://doi.org/10.3747/co.v16i3.447

APA Style

Hauschild, A. (2009). Adjuvant Interferon Alfa for Melanoma: New Evidence-Based Treatment Recommendations? Current Oncology, 16(3), 3-6. https://doi.org/10.3747/co.v16i3.447

Article Metrics

Back to TopTop